Lineage Cell Therapeutics Share Price Today
(NASDAQ: LCTX)
Lineage Cell Therapeutics share price is $0.41 & ₹35.04 as on 18 Apr 2025, 2.30 'hrs' IST
$0.41
Market is closed - opens 7 PM, 21 Apr 2025
View live Lineage Cell Therapeutics share price in Dollar and Rupees. Guide to invest in Lineage Cell Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lineage Cell Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Lineage Cell Therapeutics share price movements
- Today's Low: $0.41Today's High: $0.43
0.02%
Downside
Day's Volatility :3.8%
Upside
3.78%
- 52 Weeks Low: $0.3752 Weeks High: $1.40
10.95%
Downside
52 Weeks Volatility :73.92%
Upside
70.71%
Lineage Cell Therapeutics (LCTX) Returns
Lineage Cell Therapeutics (LCTX) Key Statistics
in dollars & INR
How to invest in Lineage Cell Therapeutics Stock (LCTX) from India?
It is very easy for Indian residents to invest directly in Lineage Cell Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lineage Cell Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lineage Cell Therapeutics or LCTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lineage Cell Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Lineage Cell Therapeutics shares which would translate to 2.085 fractional shares of Lineage Cell Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lineage Cell Therapeutics, in just a few clicks!
Returns in Lineage Cell Therapeutics (LCTX) for Indian investors in Rupees
The Lineage Cell Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Lineage Cell Therapeutics investment value today
Current value as on today
₹37,993
Returns
Returns from Lineage Cell Therapeutics Stock
Dollar Returns
₹2,341 (+2.34%)
Indian investors sentiment towards Lineage Cell Therapeutics (LCTX)
Analyst Recommendation on Lineage Cell Therapeutics
Buy
83%Buy
16%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Lineage Cell Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Lineage Cell Therapeutics Stock (LCTX)
What analysts predicted
Upside of 855.29%
Target:
$3.92
Current:
$0.41
Insights on Lineage Cell Therapeutics Stock (Ticker Symbol: LCTX)
Price Movement
In the last 7 days, LCTX stock has moved down by -11.3%Decreasing Revenue
Revenue is down for the last 2 quarters, 3.77M → 2.86M (in $), with an average decrease of 24.1% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -3.03M → -3.27M (in $), with an average decrease of 7.9% per quarterLCTX vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 139.9%LCTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 96.1%Price to Sales
ForLCTX every $1 of sales, investors are willing to pay $8.7, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.
Lineage Cell Therapeutics Technicals Summary
Sell
Neutral
Buy
Lineage Cell Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Lineage Cell Therapeutics (LCTX) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -16.64% | -52.68% | -64.35% | -67.72% | -43.91% |
 | -17.1% | -41.85% | -37.2% | -21.74% | -0.85% |
 | -13.12% | 5.03% | 78.34% | 40.23% | 43.44% |
 | -4.76% | 2.3% | 24.05% | 71.43% | 78.99% |
 | -9.09% | -19.67% | 62.43% | 39.66% | 61.91% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.12 | -0.27 | -0.13 | NA | 0.36 |
| 14.68 | 14.68 | 0.9 | 41.18 | 0.16 | 0.07 | 0.01 | 273.57 |
| NA | NA | NA | 1.09 | -0.19 | -0.06 | NA | 31.22 |
| 32.84 | NA | 1.34 | 17.96 | -0.03 | 0.13 | NA | 63.87 |
| NA | NA | -0.49 | 0.81 | -15.01 | -0.03 | NA | 0.52 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $93.6M | -43.91% | NA | -195.9% |
| Buy | $60.5B | -0.85% | 14.68 | 31.07% |
| NA | $26.9B | 43.44% | NA | -16.92% |
| Buy | $125.7B | 78.99% | 32.84 | -4.86% |
| Buy | $30.4B | 61.91% | NA | -12.37% |
About Lineage Cell Therapeutics
Management People of Lineage Cell Therapeutics
Important FAQs about investing in LCTX Stock from India :
What is Lineage Cell Therapeutics share price today?
Lineage Cell Therapeutics share price today stands at $0.41, Open: $0.41 ; Previous Close: $0.42 ; High: $0.43 ; Low: $0.41 ; 52 Week High: $1.40 ; 52 Week Low: $0.37.
The stock opens at $0.41, after a previous close of $0.42. The stock reached a daily high of $0.43 and a low of $0.41, with a 52-week high of $1.40 and a 52-week low of $0.37.
Can Indians buy Lineage Cell Therapeutics shares?
Yes, Indians can invest in the Lineage Cell Therapeutics (LCTX) from India.
With INDmoney, you can buy Lineage Cell Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Lineage Cell Therapeutics at zero transaction cost.
How can I buy Lineage Cell Therapeutics shares from India?
It is very easy to buy Lineage Cell Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Lineage Cell Therapeutics (LCTX) be purchased?
Yes, you can buy fractional shares of Lineage Cell Therapeutics with INDmoney app.
What are the documents required to start investing in Lineage Cell Therapeutics stocks?
To start investing in Lineage Cell Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Lineage Cell Therapeutics Stock (LCTX)?
Today’s highest price of Lineage Cell Therapeutics (LCTX) is $0.43.
Today’s lowest price of Lineage Cell Therapeutics (LCTX) is $0.41.
What is today's market capitalisation of Lineage Cell Therapeutics?
What is the 52 Week High and Low Range of Lineage Cell Therapeutics Stock (LCTX)?
52 Week High
$1.40
52 Week Low
$0.37
What are the historical returns of Lineage Cell Therapeutics (LCTX)?
1 Month Returns
-16.64%
3 Months Returns
-52.68%
1 Year Returns
-64.35%
5 Years Returns
-43.91%
Who is the Chief Executive Officer (CEO) of Lineage Cell Therapeutics ?
Discover More
- Alps Clean Energy Etf
$21.85
+1.86%
Scpharmaceuticals Inc$2.57
+0.78%
Kentucky First Federal Bancorp$2.71
-1.45%
- Energys Group Ltd.
$5.11
+2.72%
Rogers Corp$53.92
+2.33%
Arcutis Biotherapeutics Inc$13.01
+0.39%
Spdr S&p China Etf$78.10
+0.04%
Simplify Interest Rate Hedge Etf$54.85
+3.28%
Sight Sciences Inc$2.66
+1.92%